Immune suppression could improve treatments
A robotic approach may be the right choice for the toughest cases
Gene assay could aid treatment decisions
Procedure has potential benefits but entails teamwork
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Researchers validate a 16-gene assay
TKI therapy can shrink tumor, make partial nephrectomy feasible
Findings presented at ASCO GU
Single kidney, multiple renal masses may be indications
Evidence-based medicine can raise the standard of care